Rankings
▼
Calendar
HRTX Q4 2025 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$41M
-0.5% YoY
Gross Profit
$33M
81.2% margin
Operating Income
$38,000
0.1% margin
Net Income
-$3M
-7.3% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+6.2%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$256M
Total Liabilities
$242M
Stockholders' Equity
$14M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41M
$41M
-0.5%
Gross Profit
$33M
$31M
+7.8%
Operating Income
$38,000
$4M
-99.1%
Net Income
-$3M
$4M
-180.6%
Revenue Segments
C I N V A N T I
$23M
62%
Z Y N R E L E F
$13M
34%
S U S T O L
$1M
4%
← FY 2025
All Quarters